2023 Supreme(Del) 2185
AMIT BANSAL
Boehringer Ingelheim Pharma Gmbh & Co. Kg – Appellant
Versus
Vee Excel Drugs And Pharmaceuticals Private Ltd. – Respondent
Advocates appeared:
Dr. Sanjay Kumar, Ms. Arpita Sawhney, Mr. Arun Kumar Jana, Ms. Meenal Khurana, Mr. Harshit Dixit and Mr. Priyansh Sharma, Advocates, for the Plaintiff in CS(COMM) 239 of 2019 & CCP(O) 82 of 2019, I.A. 6797 of 2019 (O-XXXIX R-1 & 2 of CPC), I.A. 9272 of 2019 (O-VII R-11 of CPC), I.A. 2042 of 2020 (u of S 151 CPC), I.A. 2044 of 2020 (u of s 151 CPC) & CS(COMM) 240/2019 & CCP(O) 81/2019, I.A. 6802/2019 (OXXXIX R-1 & 2 of CPC), I.A. 9277/2019 (O-VII R-11 of CPC), I.A. 2036/2020 (u/S 151 CPC), I.A.2038/2020 (u/S 151 CPC) & CS(COMM) 236/2022, & I.A. 5801/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5802/2022(O-XXVI R-9 of CPC), I.A. 5803/2022(O-XI R-1 (6) as amended by the Commercial Court Act), I.A. 5804/2022 (for directions), I.A.22459/2022 (for condonation of delay of 88 days in WS to the CC) & CS(COMM) 296/2022 & I.A. 7109/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 7110/2022 (O-XXVI R-9 of CPC), I.A. 7111/2022 (OXI R-1 (6) as amended by the Commercial Court Act), 7112/2022 (for directions), I.A. 11729/2022 (u/S 151 CPC).
Mr. Mukesh Rana and Ms. Mamta, Advocates, for the Defendants No.1 and 2 in CS(COMM) 239 of 2019 & CCP(O) 82 of 2019, I.A. 6797 of 2019 (O-XXXIX R-1 & 2 of CPC), I.A. 9272 of 2019 (O-VII R-11 of CPC), I.A. 2042 of 2020 (u of S 151 CPC), I.A. 2044 of 2020 (u of s 151 CPC) & CS(COMM) 240/2019 & CCP(O) 81/2019, I.A. 6802/2019 (OXXXIX R-1 & 2 of CPC), I.A. 9277/2019 (O-VII R-11 of CPC), I.A. 2036/2020 (u/S 151 CPC), I.A.2038/2020 (u/S 151 CPC).
Mr. Adarsh Ramanujan, Ms. Bitika Sharma, Ms. Nitya Sharma, Ms. Vrinda Pathak, Mr. George Vithayathil and Mr. Skanda Shekhar, Advocates, for the Respondent in CS(COMM) 236/2022, & I.A. 5801/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5802/2022(O-XXVI R-9 of CPC), I.A. 5803/2022(O-XI R-1 (6) as amended by the Commercial Court Act), I.A. 5804/2022 (for directions), I.A.22459/2022 (for condonation of delay of 88 days in WS to the CC)
Mr. Ashok Aggarwal, Senior Advocate with Dr. Sanjay Kumar, Ms. Arpita Sawhney, Mr. Arun Kumar Jana, Ms. Meenal Khurana, Mr. Harshit Dixit and Mr. Priyansh Sharma, Advocates, for the Petitioner in CS(COMM) 237/2022 & I.A. 5806/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5807/2022 (O-XXVI R-9 of CPC), I.A. 5808/2022 (OXI R-1 (6) as amended by the Commercial Court Act), I.A. 5809/2022 (for directions) & CS(COMM) 238/2022 & I.A. 5811/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5812/2022 (O-XXVI R-9 of CPC), I.A. 5813/2022 (OXI R-1 (6) as amended by the Commercial Court Act), I.A. 5814/2022 (for directions).
Mr. G. Nataraj, Mr. Ankur Vyas, Mr. Shashi Kant Yadav, Ms. Garima Joshi, Ms. Harshita Agarwal, Mr.Avinash K.Sharma, Mr.R.Abhishek and Mr. Rahul Bhujbal, Advocates, for the Respondent in CS(COMM) 237/2022 & I.A. 5806/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5807/2022 (O-XXVI R-9 of CPC), I.A. 5808/2022 (OXI R-1 (6) as amended by the Commercial Court Act), I.A. 5809/2022 (for directions).
Mr. J. Sai Deepak, Mr. G. Nataraj, Mr. Ankur Vyas, Mr. Shashi Kant Yadav, Ms. Garima Joshi, Ms. Harshita Agarwal, Mr.Avinash K.Sharma, Mr.R.Abhishek and Mr. Rahul Bhujbal, Advocates, for the Respondent in CS(COMM) 238/2022 & I.A. 5811/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 5812/2022 (O-XXVI R-9 of CPC), I.A. 5813/2022 (OXI R-1 (6) as amended by the Commercial Court Act), I.A. 5814/2022 (for directions).
Ms. Bitika Sharma, Ms. Nitya Sharma, Ms. Vrinda Pathak and Mr. George Vithayathil, Advocates, for the Respondent in CS(COMM) 296/2022 & I.A. 7109/2022 (O-XXXIX R-1 & 2 of CPC), I.A. 7110/2022 (O-XXVI R-9 of CPC), I.A. 7111/2022 (OXI R-1 (6) as amended by the Commercial Court Act), 7112/2022 (for directions), I.A. 11729/2022 (u/S 151 CPC).
JUDGMENT
Amit Bansal, J.
I.A. 6797/2019 (O-XXXIX R-1 & 2 of CPC) in CS(COMM)239/2019
I.A. 6802/2019 (O-XXXIX R-1 & 2 of CPC) in CS(COMM) 240/2019
I.A. 5801/2022 (O-XXXIX R-1 & 2 of CPC) in CS(COMM) 236/2022
I.A. 5806/2022 (O-XXXIX R-1 & 2 of CPC) in CS(COMM) 237/2022
I.A. 5811/2022 (O-XXXIX R-1 & 2 of CPC) in CS(COMM) 238/2022
I.A. 7109/2022 (O-XXXIX R-1 & 2 of CPC) in CS(COMM) 296/2022
1. The present six suits have been filed on behalf of the plaintiff no.1, Boehringer Ingelheim Pharma Gmbh And Co. Kg and its group company, plaintiff no.2, Boehringer Ingelheim (India) Pvt. Ltd, against various defendants, who are Indian Pharmaceutical Companies, seeking permanent injunction restraining the defendants from infringing Indian Patent No. IN 243301 titled "8-(3 AMINOPIPERIDIN-1-YL)-XANTHINE COMPOUNDS". All the aforesaid six suits were accompanied by applications for grant of interim injunction under Order XXXIX Rules 1 and 2 of Code of Civil Procedure, 1908 (CPC).
Proceedings in the suits
2. Summons in CS(COMM) 239/2019 and CS(COMM) 240/2019 were issued on 10th May, 2019 and an ad interim injunction was granted in favour of the plaintiffs restraining the defendants from manufacturing LINAGL
Click Here to Read the rest of this document
Back
